Dissolution Testing of Calcium Phosphate Coatings per ISO

Dissolution testing of calcium phosphate coatings per ISO measures how much calcium and phosphate a plasma-sprayed coating releases into a buffered medium over defined immersion periods. Coated specimens are immersed, aliquots are analyzed by ICP-OES, and mass loss is determined gravimetrically. The results document dissolution behavior for implant coating qualification.

Calcium phosphate coatings, principally hydroxyapatite, are plasma-sprayed onto orthopedic and dental implants to promote osseointegration. The test object is the coated specimen or the detached coating itself, which is characterized for composition and mass loss. This article covers the dissolution principle, sample preparation, the analytical methods of ICP-OES and gravimetric analysis, precision and recovery metrics, and acceptance criteria. Together with coating thickness measurement and adhesion testing, dissolution data form part of the chemical performance profile required for implant coating qualification.

Principle & mechanism

Dissolution testing rests on the thermodynamic instability of calcium phosphate phases in aqueous solution. Hydroxyapatite is the least soluble calcium phosphate at near-neutral pH. Even so, it releases ions according to its solubility product. When a coated specimen is immersed in a buffered medium, the crystal lattice breaks down at the surface. Calcium ions detach from the lattice, phosphate groups enter solution, and hydroxide joins the acid-base equilibrium. The dissolution rate depends on crystallinity, phase purity, porosity, and surface area. Amorphous calcium phosphate and tricalcium phosphate dissolve faster than crystalline hydroxyapatite. The mechanism therefore links coating microstructure to ion release kinetics. For this reason, crystallinity assessment by XRD is often performed alongside dissolution studies.

Coating

dissolution principle and mechanism

Under ISO framework conditions, dissolution is treated as a controlled interfacial reaction, not simple chemical erosion. The immersion medium is typically a pH-buffered saline or simulated body fluid. It is held at physiological temperature so that ionic exchange mimics in-vitro conditions. As the coating dissolves, calcium and phosphorus concentrations in the medium rise over time. Sampling at successive intervals yields a release profile. Local pH shifts, calcium supersaturation near the surface, and re-precipitation of apatite can slow or reverse the net release. Agitation and solution renewal are therefore specified to keep the driving force constant. These coupled mechanisms explain why dissolution behavior cannot be inferred from composition alone.

Sample preparation and coating specimens

Specimens are prepared as flat coupons or finished implants. They carry the production plasma-sprayed coating, and the coating process must match the process used commercially. Before immersion, each specimen is cleaned with ethanol and deionized water. It is then dried to constant mass and weighed on an analytical balance. Where the coating itself is analyzed as a powder, it is detached from the substrate mechanically and sieved to a defined particle range. Particle size affects the apparent dissolution rate. Surface area may be estimated geometrically or measured. Coating thickness is verified separately per ISO requirements, as described in articles on hydroxyapatite coating thickness measurement. Thickness influences the total ion release available. Duplicate or triplicate specimens are recommended for statistical validity.

Test

method: ICP-OES and gravimetric analysis

The core procedure combines quantitative solution analysis with mass-loss measurement. Specimens are immersed in a fixed volume of buffered medium at a controlled temperature for defined periods. At each interval, aliquots are withdrawn and acidified. They are analyzed by inductively coupled plasma optical emission spectrometry (ICP-OES) against calibrated standards. This determines calcium and phosphorus concentrations. The Ca/P ratio of the released ions can also be calculated. After the final interval, specimens are rinsed, dried to constant mass, and reweighed. The gravimetric mass loss is compared with the cumulative ion release to check internal consistency. This dual approach parallels the ICP-OES procedures used in Ca/P ratio analysis of hydroxyapatite. Here it is applied to the dissolved fraction.

Performance

metrics: precision and recovery

Data quality is judged through replicate precision and spike recovery. Precision is expressed as the relative standard deviation of calcium and phosphorus determinations. It covers parallel specimens and repeated measurements. ICP-OES typically supports low replicate variability when calibration and matrix matching are controlled. Recovery is assessed by spiking immersion media with known amounts of calcium and phosphorus standards. Measured values must fall within the acceptance band of the method. Blank media are run to correct background contamination. Gravimetric mass balance should agree with the ion-release estimate within the stated tolerance. A large discrepancy signals coating spallation rather than dissolution, and it must be reported as such. These checks give the release profile its analytical credibility.

Acceptance

criteria and application scenarios

Acceptance is typically defined by the product specification or the applicable part of the ISO 13779 series, not by a single universal limit. Criteria may include a maximum cumulative calcium release, a mass-loss limit per unit area, and retention of coating integrity after immersion. Dissolution results are read together with adhesion and shear testing of calcium phosphate implant coatings. A coating that releases ions too readily may also lose mechanical attachment. Applications cover implant coating qualification, batch release, comparison of spray parameters, and stability screening of new coating formulations. The resulting report supports regulatory submissions, supplier qualification, and internal quality control. Dissolution behavior is also considered alongside biocompatibility assessment under ISO 10993.